Merck KGaA (Darmstadt, Germany) is looking to strengthen its presence in the prescription pharmaceuticals market in the United States and is open to more collaborations and acquisitions. At todayâ€™s press briefing in Yavne, Israel, the location of Merck Seronoâ€™s subsidiary in Israel, Stefan Oschmann, board member Merck KGaA/pharma and consumer health, said that the average global pharma company generates about 50% of its sales in the US while Merckâ€™s share is only 20%. He said that Merck is planning to raise this soon and that may include M&A. â€œThe US...
Access is for Chemweek 24/7 PLUS Members ONLY
This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information.
Forgot your user ID or password? Click here to have it sent to you.